KI-Beratung Beta
Vor Ort
Merkzettel Warenkorb

Gutscheinbedingungen

**Gültig am 01.10.2026 ab einem Mindestbestellwert von 30€ auf Spielzeug, Schreibwaren, Filme, Geschenke & Trends, Musik, tolino eReader & Zubehör, Hörbücher und Hörbuch-Downloads, nicht preisgebundene Bücher und Kalender online auf thalia.at und in der Thalia App. Einzelne Artikel können ausgeschlossen sein. Aufgrund der Buchpreisbindung sind deutschsprachige Bücher und eBooks ausgenommen. Zusätzlich ausgenommen sind Abos & Flatrates, Games, Geschenkkarten/-boxen, Shelfies, Software, Zeitschriften sowie einzelne Artikel von tonies®. Pro Einkauf einmal einlösbar. Click & Collect nur bei Onlinevorabzahlung möglich. Keine Barauszahlung. Nicht kombinierbar mit anderen Aktionen und Gutscheinen. Gutschein wird auf max. 500€ Bestellwert angerechnet. Nicht gültig für Versandkosten und Services. Preisgebundene Artikel sind vom Mindestbestellwert ausgeschlossen.
Produktbild: Redefining the Microrna Functionality in Cancer Diagnostics and Therapeutics
Vorbesteller Neu

Redefining the Microrna Functionality in Cancer Diagnostics and Therapeutics

195,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.05.2027

Herausgeber

Vivek Kumar + weitere

Verlag

Elsevier

Seitenzahl

330

Maße (L/B)

23,5/19,1 cm

Gewicht

449 g

Sprache

Englisch

ISBN

978-0-443-45952-8

Beschreibung

Portrait

Dr. Vivek Kumar is a postdoctoral researcher at the University of South Florida, specializing in the study of the human microbiome, epigenetic mechanisms, and neurodegeneration. His research focuses on multi-omics integration to identify biomarkers for cognitive impairment and Alzheimer’s disease, utilizing advanced statistical modeling and machine learning for host-microbe interaction analysis through saliva-based diagnostics. Previously, he completed a postdoctoral fellowship at AIIMS Patna, contributing to translational cancer research on epigenetic dysregulation of microRNAs in triple-negative breast cancer. He earned his Ph.D. in Biotechnology from Motilal Nehru National Institute of Technology, India, with a focus on epigenetics and non-coding RNAs in ovarian cancer. His expertise includes microbiome profiling, methylation analysis, miRNA quantification, and systems biology approaches. Dr. Kumar has extensive experience with molecular techniques and bioinformatics tools, and he has published numerous peer-reviewed articles. He also serves as a reviewer for leading journals in oncology, bioinformatics, and molecular diagnostics.

Dr. Rohit Shukla holds a Ph.D. from Jaypee University of Information Technology, India, and is currently a Postdoctoral Research Fellow at the University of South Florida. His research focuses on metagenomics and multi-omics studies of microbiome-host interactions related to Alzheimer’s disease, exploring biomarkers and therapeutic targets through genome sequencing, taxonomic profiling, and microbial causal inference. He also works in transcriptomics, miRNA analysis, single-cell, and epigenetics. His Ph.D. research involved annotating hypothetical proteins, identifying biomarker genes using machine learning, and in silico drug target discovery. Skilled in tools like QIIME2, Kraken2, and Galaxy, he is developing diagnostic biomarkers and saliva-based early detection assays for Alzheimer’s. Rohit has published extensively and reviews for reputable journals. With a multidisciplinary background, he aims to advance precision diagnostics and therapeutic strategies through systems biology and integrative omics approaches.

Dr. Amit Chaudhary is a Postdoctoral Scholar at the University of Alabama at Birmingham, working on deorphanizing G-protein-coupled receptors (GPCRs). His research interests include genomics, structural bioinformatics, and biophysics. Previously, he was a postdoctoral fellow at IIT Bombay in the Polymer Simulation and Characterization Lab. He earned his Ph.D. in Biotechnology from Motilal Nehru National Institute of Technology, Allahabad, and holds an M.Tech. in Bioinformatics from IIIT Allahabad, as well as a Bachelor of Pharmacy from the United Institute of Pharmacy, Allahabad. His expertise spans transcriptomics, molecular modeling, docking, molecular dynamics, phylogenetics, and protein-gene interaction analysis. Dr. Chaudhary's work focuses on functional and pathway analysis of proteins and genes, aiming to advance understanding in molecular biology and computational biochemistry.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

01.05.2027

Herausgeber

Verlag

Elsevier

Seitenzahl

330

Maße (L/B)

23,5/19,1 cm

Gewicht

449 g

Sprache

Englisch

ISBN

978-0-443-45952-8

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Redefining the Microrna Functionality in Cancer Diagnostics and Therapeutics

  • 1. miRNA Biology Reexplored: Beyond Traditional Functions
    2. Epigenetic and Environmental Modulation of miRNAs in Cancer
    3. Integration of miRNAs with Multi-Omics Data: A Systems Biology Approach
    4. Machine Learning and AI Models for miRNA-Based Diagnostics
    5. Single-Cell miRNA Profiling: Tools and Applications
    6. miRNA Engineering: CRISPR/Cas Systems, Synthetic Circuits, and RNA Devices
    7. Theranostic miRNAs: Dual Role in Imaging and Therapy
    8. Clinical Translation: Liquid Biopsies, Trials, and Companion Diagnostics
    9. miRNA-Based Biosensors and Point-of-Care Technologies
    10. Immuno-Oncology and miRNA Crosstalk in the Tumor Microenvironment
    11. AI-Powered Drug Discovery and Repurposing via miRNA Signatures
    12. Intellectual Property and Patent Landscape in miRNA Diagnostics
    13. Case Studies: Ovarian, Breast, and Brain Tumors-From Bench to Bedside
    14. MiRNA Drugs in Clinical Practice
    15. Current challenges, limitations, and regulatory hurdles in translating miRNA research into clinical practice